Scientific Opinion on the Tolerable Upper Intake Level of calcium

被引:49
作者
Agostoni, Carlo [1 ]
Bresson, Jean-Louis [1 ]
Fairweather-Tait, Susan [1 ]
Flynn, Albert [1 ]
Golly, Ines [1 ]
Korhonen, Harmu [1 ]
Lagiou, Pagona [1 ]
Lovik, Martinus [1 ]
Marchelli, Rosangela [1 ]
Martin, Ambroise [1 ]
Moseley, Bevan [1 ]
Neuhaeuser-Berthold, Monika [1 ]
Przyrembel, Hildegard [1 ]
Salminen, Seppo [1 ]
Sanz, Yolanda [1 ]
Strain, Sean [1 ]
Strobel, Stephan [1 ]
Tetens, Inge [1 ]
Tome, Daniel [1 ]
van Loveren, Hendrik [1 ]
Verhagen, Hans [1 ]
机构
[1] EFSA, Parma, Italy
关键词
Calcium; supplements; hypercalcaemia; hypercalciuria; UL; safety;
D O I
10.2903/j.efsa.2012.2814
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to re-evaluate the safety in use of calcium. The Panel was requested to consider if the Tolerable Upper Intake Level (UL) for calcium established by the SCF in 2003 (2,500 mg/day for adults, including pregnant and lactating women), which was based on different intervention studies of long duration in which total daily calcium intakes of 2,500 mg from both diet and supplements were tolerated without adverse effects, needed to be changed on the basis of new available evidence. A number of placebo controlled human intervention studies in adults published since then also showed that total daily calcium intakes of 2,500 mg from both diet and supplements are tolerated without adverse effects. The Panel considers that no relationship has been established between long-term calcium intakes from diet and supplements and increased risk of nephrolithiasis, cardiovascular disease or prostate cancer. No new data have become available which would require a revision of the UL for calcium for adults, including pregnant and lactating women, of 2,500 mg. No new data have become available which would allow the setting of a UL for infants, children or adolescents. Data from European populations indicate that intakes of calcium in high consumers among adult males can be close to the UL. Although available data do not allow the setting of a UL for infants, children or adolescents, no risk has been identified with highest current levels of calcium intake in these age groups. (C) European Food Safety Authority, 2012.
引用
收藏
页数:44
相关论文
共 152 条
[11]  
Becker W, 2002, RIKSMATEN 1997 1998
[12]   Calcium intake and prostate cancer risk in a long-term aging study: The Baltimore Longitudinal Study of Aging [J].
Berndt, SI ;
Carter, HB ;
Landis, PK ;
Tucker, KL ;
Hsieh, LJ ;
Metter, EJ ;
Platz, EA .
UROLOGY, 2002, 60 (06) :1118-1123
[13]   Oral Calcium Supplements Do Not Affect the Progression of Aortic Valve Calcification or Coronary Artery Calcification [J].
Bhakta, Mayurkumar ;
Bruce, Charles ;
Messika-Zeitoun, David ;
Bielak, Lawrence ;
Sheedy, Patrick F. ;
Peyser, Patricia ;
Sarano, Maurice .
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2009, 22 (06) :610-616
[14]   Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis [J].
Block, GA ;
Spiegel, DM ;
Ehrlich, J ;
Mehta, R ;
Lindbergh, J ;
Dreisbach, A ;
Raggi, P .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1815-1824
[15]  
BOING H, 1985, Nutrition and Cancer, V7, P121
[16]   Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial [J].
Bolland, Mark J. ;
Barber, P. Alan ;
Doughty, Robert N. ;
Mason, Barbara ;
Horne, Anne ;
Ames, Ruth ;
Gamble, Gregory D. ;
Grey, Andrew ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7638) :262-266
[17]   Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis [J].
Bolland, Mark J. ;
Grey, Andrew ;
Avenell, Alison ;
Gamble, Greg D. ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[18]   Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis [J].
Bolland, Mark J. ;
Avenell, Alison ;
Baron, John A. ;
Grey, Andrew ;
MacLennan, Graeme S. ;
Gamble, Greg D. ;
Reid, Ian R. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 :289
[19]   Calcium and fibre supplementation in prevention of colorectal adenoma recurrence:: a randomised intervention trial [J].
Bonithon-Kopp, C ;
Kronborg, O ;
Giacosa, A ;
Räth, U ;
Faivre, J .
LANCET, 2000, 356 (9238) :1300-1306
[20]   Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density [J].
Bonnick, Sydney ;
Broy, Susan ;
Kaiser, Fran ;
Teutsch, Carol ;
Rosenberg, Elizabeth ;
DeLucca, Paul ;
Melton, Mary .
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (06) :1341-1349